Navigation Links
Attorney General Eric Holder to Be Honored by Whitman-Walker Clinic
Date:6/8/2009

WASHINGTON, June 8 /PRNewswire-USNewswire/ -- Attorney General Eric Holder will be honored and deliver brief remarks at the Whitman-Walker Clinic's "Going the Extra Mile" Reception and Awards Ceremony on TUESDAY, JUNE 9, 2009 at 8:30 P.M. ET. The clinic's Legal Services Program will present the Joel A. Toubin Memorial Award to the Attorney General.

WHO: Attorney General Eric Holder

WHAT: To be honored and deliver brief remarks at the Whitman-Walker Clinic's "Going the Extra Mile" Reception and Awards Ceremony

WHEN: TUESDAY, JUNE 9, 2009

8:30 P.M. ET

WHERE: Embassy of Italy

3000 Whitehaven Street N.W.

Washington, D.C.

OPEN PRESS

NOTE: All media must present government-issued photo I.D. (such as a driver's license) and valid media credentials. Media may begin arriving at 7:30 P.M. ET and cameras must be pre-set by 8:00 P.M. ET. The reception begins at 6:30 P.M. ET and the Attorney General will speak at approximately 8:30 P.M. Press inquiries regarding logistics should be directed to Ellie Willard at 202-797-3543 or ewillard@wwc.org.


'/>"/>
SOURCE U.S. Department of Justice
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Avandia Attorney Says Study Based on Useless Trick Science
2. Statement of the Attorney General on Murder of Doctor George Tiller
3. LawInfo Provides Access to Qualified Hydroxycut Litigation Attorneys Nationwide
4. Jonathan Perkins Injury Lawyers Adds Two Experienced Litigation Attorneys to Connecticut Team
5. Manhattan Personal Injury Attorney Blames Insurance Industry For Negative Perception Of Civil Justice System
6. UPDATE: Swine Flu Spread Will Trigger Difficult Legal Questions for Employers Says Noted Pillsbury Attorney
7. Asbestos Judges, Attorneys Holding Judicial Forum June 3
8. Swine Flu Plans Triggering Difficult Legal Questions, Says Noted Pillsbury Attorney
9. Attorney General Eric Holder Honors Florida Doctor and Announces $4.7 Million in Recovery Act Funds for State
10. Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related to the Ongoing United States Attorneys Office Investigation
11. Social Security Attorney Directory Helps to Speed SSDI Benefits

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...TO,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...tionsoftwarelaunchesasuiteofnewleadingedgeclinical...atformatthisyear,sRadiologicalSocietyofNorthAmeric...oth5800,HallA).Theapplicationsleveragetheuniquehig...Iimagingcoilsandsupportmultipleimagingmodalitiesfo...
(Date:11/25/2009)...GELES,Nov.25/PRNewswire-USNewswire/--TheBlackAIDSI...rmineexecutiveleadershipfor2010. ,, ThenewBoard...iesinpublicpolicy,law,finance,governmenthealthprog...dalsocomesfromawiderangeofpersonalbackgroundsinclu...ingwithHIVthemselves,andrepresentingmultipleagegro...
(Date:11/25/2009)...urvivors of testicular cancer who were treated wit...e effects, including neurological side effects and...ated with chemotherapy, according to a new study p... National Cancer Institute . , Marianne Brydy, M...ersity Hospital, in Bergen, Norway, and colleagues...
(Date:11/25/2009)... increase blood pressure? This simple question ha...s. New Stress-related gene Modulates High Blood P... pressure? This simple question has been the focu...earch has for the first time established a link be...ure response to stress in mice as well as humans. ...
(Date:11/25/2009)... Evaluation and treatment clinics to r...oodstock (Vocus) November 25, 2009 -- Centegra Hea...nes and H1N1 vaccine shots at four Centegra Primar...pment of vaccine has arrived. The clinics are at C...cHenry and will be open as follows: ,   ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...a,AFL-CIO President William George and Secretary T...ppointment in the latest decisions by,Representati...er to play,partisan politics with health insurance...ntatives Peterson, Pitts and Shuster could have ch...
...nson,Pharmaceutical Research & Development, L.L.C....ation (NDA) to the U.S. Food and Drug,Administrati...lease (IR),tablets, an investigational oral analge... each year as a result of injuries or,surgeries, a...
...ific (NYSE: BSX ),today issued the following stat... Scientific Officer, on an article in the New Engl...Bare-Metal and Drug-Eluting Stents for,Off-Label I...s the latest,in a series of studies that have led ...
... five years without anti-rejection drugs , ...es that allow organ transplant recipients to stop ...ng to come to fruition. , "The next stage in the d...s of the lifelong immunosuppressive drugs," said D...
...nthesis method based on a catalyst worth many time...ient and economical method than traditional ones f...rmaceutical compounds is described by its Universi...ium Technologies, LLC in Buffalo, has the potentia...
...ight to site of blood clot, study reports , ...s that attack blood clots directly in the brain ma...nd to the standard treatment using clot-busting dr...Fla. , Ischemic strokes -- which account for about...
Other Medicine News:Health News:Pennsylvania AFL-CIO Decries Shameful Votes Again by Representatives John Peterson, Joe Pitts and Bill Shuster, Against Children's Health Care 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 3Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 4Health News:Boston Scientific Comments on New England Journal of Medicine Article 2Health News:Boston Scientific Comments on New England Journal of Medicine Article 3Health News:New Therapies Could Change Organ Transplants 2Health News:New Therapies Could Change Organ Transplants 3Health News:New method enables design, production of extremely novel drugs 2Health News:New method enables design, production of extremely novel drugs 3Health News:Advanced Therapy Aids Stroke Patients 2Health News:Advanced Therapy Aids Stroke Patients 3
(Date:11/25/2009)...ALMBEACH,Fla.,Nov.25/PRNewswire-FirstCall/--Forman...ythe27millionlivingwithuntreated hearingloss ,theh...yer. ,, Dr.Beyer,seniorvicepresidentofHearUSA(A...ringaids companies,saidstudieshavelinkedhearinglos...easilybeintensifiedatholidaygatheringswithfamilies...
(Date:11/25/2009)...RK,Nov.25/PRNewswire/--Reportlinker.comannouncesth...e: ,, UnitedStatesDentalDevicesMarketAnalysisa...com/p0158733/United-States-Dental-Devices-Market-A...atesDentalDevicesMarketAnalysisandForecaststo2015 ...eforin-depthinformationanddatarelatingtotheUSdenta...
(Date:11/25/2009)...EGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(Na...ingproductsforminimallydisruptivesurgicaltreatment...cecallonMonday,November30,2009,at5:30p.m.ET/2:30p....tivetoreimbursementfortheCompany,sproductsandwilli...onandanswersession.Thedial-innumbersare1-877-407-4...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Orexigen 28R 29 Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings 12414 1Orexigen 28R 29 Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings 12414 2The Unexpected Gifts of Alzheimers 47597 1The Unexpected Gifts of Alzheimers 47597 2The Unexpected Gifts of Alzheimers 47597 3Spurwink Services Unveils Spruce Point 47593 1Spurwink Services Unveils Spruce Point 47593 2
...ew analysis of landmark study showed patients taki...nt of recurrent heart attack, stroke or cardiovas...opidogrel, TOKYO and INDIANAPOLIS, Aug. 21 A new...head-to-head TRITON-TIMI,38 study showed patients ...CS) managed with an artery-opening procedure known...
...NN ARBOR, Mich., Aug. 21 /PRNewswire/ Terumo Heart...U.S. patient implanted with the,DuraHeart(TM) Left...,discharged home on August 14th, from the Universi...ing the device., The patient is a 62-year-old man...om heart failure for nearly 20 years. He is the fi...
Other Medicine Technology:Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events 2Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events 3Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events 4Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events 5Discharge of First U.S. DuraHeart(TM) Patient 2
Replacement Bulb: HBO 50W/AC/L2
Replacement Bulb: ESA/FHD
Replacement Bulb: EJA
Replacement Bulb: EFM
Medicine Products: